Oz Biosciences provide a custom mRNA service from gene synthesis to in vitro mRNA production.
Discover Oz Biosciences’ Custom and Ready-to-use mRNA service
miRNA In Situ Hybridisation
miRNA in situ hybridisation is a powerful technique that allows researchers to visualise and localise miRNAs within cells and tissues.
Explore the Limitless Potential of IL-18
Researchers take advantage of MBL International’s recombinant IL-18 to activate varying cells like peripheral blood cells, macrophages, NK cells and T cells to identify targets.
Caspase Activity: Essential for Apoptosis
MBLI ‘s APOPCYTO Caspase-3,8,9 Colorimetric Assay Kit detects caspase activity in cell extract with LEHD-pNA as a substrate, in which LEHD sequence is recognised by each active caspase selectively.
TargetMol’s Compound Libraries
What do compound libraries do? Compound libraries are widely used in target identification, high throughput/focused screening for new hits that might be developed into a drug, drug repositioning/repurposing, predictive toxicology, or new target discovery through the integration of small-molecule chemogenomics
Bispecific T-Cell Engaging (BiTE) Antibodies: A Promising Cancer Therapy
Krishgen is the only manufacturer of ELISA for pharmacokinetic studies of BsAbs, with 40+ drug targets in a sensitive, highly specific ELISA format.
2D Differentiation of Epithelial Cells, Fibroblasts, and Melanocytes With Ease and Accuracy
CELLnTEC’s 2D differentiation media come in a fully supplemented, one-bottle ready-to-use formulation designed to create an environment conducive to cell differentiation.
Monoclonal vs. Polyclonal Antibodies
Leinco manufactures an extensive range of primary antibodies with the highest purity specifications available in the research products industry.
Immune Checkpoint Mechanism of Action
Leinco Technologies offers both GOLD™ and PLATINUM™ In vivo functional grade antibodies to important checkpoint markers for use in checkpoint research.
PhenoCycler-Fusion (CODEX)® Technology and Workflow Steps
PhenoCycler-Fusion (CODEX)® technology target subsets of an antibody panel via repetitive imaging cycles, revealing 40+ biomarkers in a tissue section.